Related Experiment Videos

Nasal colonization with methicillin-resistant Staphylococcus aureus: clinical implications and treatment

David Friedel1, Michael Climo

  • 1McGuire Veteran Affairs Medical Center, 1201 Broad Rock Boulevard, Section 111-C, Richmond, VA 23236, USA.

Current Infectious Disease Reports
|April 14, 2007
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) causes significant illness and death. Strategies to eliminate MRSA carriage are crucial for reducing infection rates.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a growing global health threat, causing severe morbidity and mortality.
  • Despite infection control efforts, MRSA prevalence has risen, becoming endemic in many healthcare settings.
  • Asymptomatic nasal carriage of MRSA is a key risk factor for developing S. aureus infections.

Purpose of the Study:

  • To explore decolonization strategies for Methicillin-resistant Staphylococcus aureus (MRSA).
  • To reduce the incidence of MRSA infections through effective decolonization.

Main Methods:

  • Review of existing decolonization approaches for MRSA.
  • Analysis of systemic antibiotics, inhalation antibiotics, antiseptic washes, and topical antimicrobials.

Main Results:

  • Decolonization strategies aim to mitigate MRSA spread and infection.
  • Various methods are being investigated to eradicate MRSA carriage.

Conclusions:

  • Effective decolonization of MRSA is essential for infection control.
  • Further research into optimal decolonization methods is warranted to combat MRSA infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...